Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)
Condition(s):Chronic Myeloid Leukemia; Ph+ Acute Lymphoblastic LeukemiaLast Updated:February 2, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Myeloid Leukemia; Ph+ Acute Lymphoblastic LeukemiaLast Updated:February 2, 2021Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:March 15, 2024Recruiting
Condition(s):Childhood Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase Chronic Myelogenous LeukemiaLast Updated:January 17, 2013Completed
Condition(s):LeukemiaLast Updated:April 28, 2017Completed
Condition(s):Chronic Myelogenous LeukemiaLast Updated:September 1, 2020Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:May 19, 2015Completed
Condition(s):LeukemiaLast Updated:February 5, 2013Completed
Condition(s):Leukemia, Chronic MyeloidLast Updated:December 4, 2023Active, not recruiting
Condition(s):LeukemiaLast Updated:June 25, 2013Completed
Condition(s):LeukemiaLast Updated:July 4, 2016Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.